002584.SZ
Get informed when a big investor buys or sells
+ FollowOvervalued by 154.7% based on the discounted cash flow analysis.
| Market cap | $4.37 Billion |
|---|---|
| Enterprise Value | $5.64 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.13 |
| Beta | 0.67 |
| Outstanding Shares | 585,216,422 |
| P/E Ratio | 111.83 |
|---|---|
| PEG | -84.29 |
| Price to Sales | 0.53 |
| Price to Book Ratio | 2.47 |
| Enterprise Value to Revenue | 0.68 |
| Enterprise Value to EBIT | 52.94 |
| Enterprise Value to Net Income | 143 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 0.82 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Xilong Scientific Co., Ltd. is a Chinese enterprise primarily engaged in the research, development, manufacturing, and distribution of chemical reagents. Its comprehensive product portfolio encompasses a wide array of specialized chemica...